Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000561007 | SCV000661755 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-10-19 | criteria provided, single submitter | clinical testing | The p.S372A variant (also known as c.1114T>G), located in coding exon 10 of the CHEK2 gene, results from a T to G substitution at nucleotide position 1114. The serine at codon 372 is replaced by alanine, an amino acid with similar properties. This serine is a target of phosphorylation, and a substitution with alanine has been shown in a cell system to be associated with a reduction of kinase response to radiation-induced DNA damage (Guo X et al, J. Biol. Chem. 2010 Oct;285(43):33348-57). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Invitae | RCV001858097 | SCV002252856 | uncertain significance | Familial cancer of breast | 2021-09-21 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with alanine at codon 372 of the CHEK2 protein (p.Ser372Ala). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and alanine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects CHEK2 function (PMID: 20713355). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 479570). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is not present in population databases (ExAC no frequency). |